scholarly article | Q13442814 |
P50 | author | Ricardo Calderon-Gonzalez | Q53159765 |
José Gómez-Román | Q56065788 | ||
Marco Marradi | Q58204611 | ||
Isabel García | Q60009601 | ||
Carmen Alvarez-Dominguez | Q64682880 | ||
Francisco Javier Freire Venegas | Q77858385 | ||
Elisabet Frande-Cabanes | Q82049510 | ||
Sonsoles Yañez-Díaz | Q114431818 | ||
P2093 | author name string | Soledad Penadés | |
Héctor Terán-Navarro | |||
Eva Ferrández-Fernández | |||
P2860 | cites work | Synthetic Nanoparticles for Vaccines and Immunotherapy | Q28085375 |
Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN. | Q33493474 | ||
Dissociation of innate immune responses in microglia infected with Listeria monocytogenes. | Q33797427 | ||
Immune reactions to Listeria monocytogenes in the brain | Q33815015 | ||
Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8(+) T cells during pregnancy | Q34455672 | ||
Two outbreaks of Listeria monocytogenes infection, Northern Spain. | Q34641614 | ||
Listeriosis during pregnancy: a case series and review of 222 cases | Q34778400 | ||
Perorally active nanomicellar formulation of quercetin in the treatment of lung cancer | Q35753059 | ||
Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines | Q36200540 | ||
Molecular Epidemiology of Invasive Listeriosis due to Listeria monocytogenes in a Spanish Hospital over a Nine-Year Study Period, 2006-2014. | Q36204032 | ||
Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice. | Q54335589 | ||
Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience | Q57948785 | ||
Studies with Listeria monocytogenes lead the way | Q83241261 | ||
Gold nanoparticles as carriers for a synthetic Streptococcus pneumoniae type 14 conjugate vaccine | Q95812278 | ||
Novel nanoparticle vaccines for Listeriosis | Q36256378 | ||
Glyconanoparticles: types, synthesis and applications in glycoscience, biomedicine and material science | Q36418242 | ||
Vaccine delivery using nanoparticles. | Q36712817 | ||
Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion | Q37156803 | ||
Cutaneous listeriosis | Q37470334 | ||
Cellular vaccines in listeriosis: role of the Listeria antigen GAPDH. | Q37595946 | ||
Listeriosis: a resurgent foodborne infection | Q37651089 | ||
Glyconanoparticles as multifunctional and multimodal carbohydrate systems. | Q38071545 | ||
Nanovaccines and their mode of action. | Q38102471 | ||
Applications of nanotechnology for immunology | Q38123937 | ||
In vitro and in vivo models to study human listeriosis: mind the gap. | Q38154361 | ||
Nanoparticle vaccines | Q38167942 | ||
Nanoparticle based tailoring of adjuvant function: the role in vaccine development | Q38493581 | ||
Alternatively activated microglia and macrophages in the central nervous system. | Q38525488 | ||
Identification and characterisation of T-cell epitopes for incorporation into dendritic cell-delivered Listeria vaccines. | Q41192471 | ||
Cheese-related listeriosis outbreak, Portugal, March 2009 to February 2012. | Q41247861 | ||
A gold glyco-nanoparticle carrying a Listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection | Q41497431 | ||
Toll-like receptor stimulation enhances phagocytosis and intracellular killing of nonencapsulated and encapsulated Streptococcus pneumoniae by murine microglia | Q41956904 | ||
'Multicopy multivalent' glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines. | Q41965469 | ||
Infection of pregnant mice with Listeria monocytogenes induces fetal bradycardia | Q46426910 | ||
TNF-alpha and IL-6 in the diagnosis of bacterial and aseptic meningitis in children | Q46866845 | ||
Tubulin cofactor B plays a role in the neuronal growth cone. | Q48312963 | ||
Risk factors, clinical features, and outcomes of listeriosis in solid-organ transplant recipients: a matched case-control study | Q48460256 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | listeriosis | Q160653 |
Listeria monocytogenes | Q292015 | ||
nanoparticle | Q61231 | ||
P577 | publication date | 2016-08-19 | |
P1433 | published in | Nanomaterials | Q27724944 |
P1476 | title | Pregnancy Vaccination with Gold Glyco-Nanoparticles Carrying Listeria monocytogenes Peptides Protects against Listeriosis and Brain- and Cutaneous-Associated Morbidities | |
P478 | volume | 6 |
Q38680785 | Applications of Gold Nanoparticles in Nanomedicine: Recent Advances in Vaccines. |
Q37448708 | Biomarker Tools to Design Clinical Vaccines Determined from a Study of Annual Listeriosis Incidence in Northern Spain. |
Q40048669 | GNP-GAPDH1-22 nanovaccines prevent neonatal listeriosis by blocking microglial apoptosis and bacterial dissemination. |
Q39419658 | Glyco-gold nanoparticles: synthesis and applications |
Q53159624 | Gold glyconanoparticles coupled to listeriolysin O 91-99 peptide serve as adjuvant therapy against melanoma. |
Q92047320 | Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases |
Q33578950 | Immunological properties of gold nanoparticles |
Q92383586 | Public health impact of foodborne exposure to naturally occurring virulence-attenuated Listeria monocytogenes: inference from mouse and mathematical models |
Q92539527 | Size and time-dependent induction of proinflammatory cytokines expression in brains of mice treated with gold nanoparticles |
Q89907143 | Subcellular Performance of Nanoparticles in Cancer Therapy |
Q48116102 | Toxoid Vaccination against Bacterial Infection Using Cell Membrane-Coated Nanoparticles. |
Search more.